#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hairy cell leukaemia Eosinophilic granulomatosis with polyangiitis Juvenile chronic myelomonocytic leukaemia Thalassaemia alpha Anti-myelin-associated glycoprotein antibodies positive Mantle cell lymphoma stage II Neuropathic arthropathy Immunodeficiency congenital Drug eruption Transferrin decreased Idiopathic intracranial hypertension Cholangitis sclerosing Hepatitis D Acute lymphocytic leukaemia Hypochondroplasia More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis Arterial tortuosity syndrome – Trials in Disease Myxofibrosarcoma – Life with Disease Systemic mastocytosis – Diagnostics Stevens-Johnson syndrome – Basic Information Ewing’s sarcoma metastatic – Life with Disease Glycogen storage disease type I – Life with Disease Primary biliary cholangitis – Trials in Disease Adrenogenital syndrome – Basic Information Methylmalonic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM SULFIDE NONAHYDRATE Cilazapril Demeclocycline Hydrochloride Tazobactam Sodium Ceftriaxone Calcium Chloride Dihydrate Lazertinib Benztropine Mesylate Pancreas Powder ZIMISLECEL CICLOPIROX Aluminium Oxide IMMUNOSTEM Niraparib Phenylbutyrate ACARBOSE Magnesium Hydroxide Munc-T3 Tazemetostat VIPOGLANSTAT More therapies…

    Learn about Your Condition

    K-ras gene mutation Eosinophilic oesophagitis Osteosarcoma recurrent Skin papilloma Respiratory tract infection Propionic acidaemia Sickle cell anaemia Insulin resistance Large cell lung cancer Trisomy 21 Stress cardiomyopathy Laryngeal cancer stage II Endometrial cancer stage IV Underweight Colorectal cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Waldenstrom’s macroglobulinaemia recurrent

  • A study to evaluate the effectiveness of epcoritamab in patients with Waldenström’s macroglobulinemia that has returned or has not responded to previous treatments.

    Recruiting

    1 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    • Waldenstrom’s macroglobulinaemia recurrent
    • Waldenstrom’s macroglobulinaemia refractory
    Investigated Drugs:
    • Epcoritamab
    Belgium Denmark The Netherlands

  • Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia recurrent
    • Chronic lymphocytic leukaemia refractory
    • Follicular lymphoma stage II
    Investigated Drugs:
    • Glofitamab
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Germany Italy Poland

  • Study of Acalabrutinib for Patients with Waldenström Macroglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    France Greece Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!